• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过改善底物 RNA 结合提高冠状病毒 2'-O-甲基转移酶活性影响病毒发病机制的自然证据。

Natural evidence of coronaviral 2'-O-methyltransferase activity affecting viral pathogenesis via improved substrate RNA binding.

机构信息

State Key Laboratory of Virology, RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.

School of Medicine, Tsinghua University, Beijing, China.

出版信息

Signal Transduct Target Ther. 2024 May 29;9(1):140. doi: 10.1038/s41392-024-01860-x.

DOI:10.1038/s41392-024-01860-x
PMID:38811528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11137015/
Abstract

Previous studies through targeted mutagenesis of K-D-K-E motif have demonstrated that 2'-O-MTase activity is essential for efficient viral replication and immune evasion. However, the K-D-K-E catalytic motif of 2'-O-MTase is highly conserved across numerous viruses, including flaviviruses, vaccinia viruses, coronaviruses, and extends even to mammals. Here, we observed a stronger 2'-O-MTase activity in SARS-CoV-2 compared to SARS-CoV, despite the presence of a consistently active catalytic center. We further identified critical residues (Leu-36, Asn-138 and Ile-153) which served as determinants of discrepancy in 2'-O-MTase activity between SARS-CoV-2 and SARS-CoV. These residues significantly enhanced the RNA binding affinity of 2'-O-MTase and boosted its versatility toward RNA substrates. Of interest, a triple substitution (Leu → Ile, Asn → His, Ile → Leu, from SARS-CoV-2 to SARS-CoV) within nsp16 resulted in a proportional reduction in viral 2'-O-methylation and impaired viral replication. Furthermore, it led to a significant upregulation of type I interferon (IFN-I) and proinflammatory cytokines both in vitro and vivo, relying on the cooperative sensing of melanoma differentiation-associated protein 5 (MDA5) and laboratory of genetics and physiology 2 (LGP2). In conclusion, our findings demonstrated that alterations in residues other than K-D-K-E of 2'-O-MTase may affect viral replication and subsequently influence pathogenesis. Monitoring changes in nsp16 residues is crucial as it may aid in identifying and assessing future alteration in viral pathogenicity resulting from natural mutations occurring in nsp16.

摘要

先前的研究通过靶向突变 K-D-K-E 基序表明,2'-O-MTase 活性对于有效的病毒复制和免疫逃逸至关重要。然而,2'-O-MTase 的 K-D-K-E 催化基序在包括黄病毒、牛痘病毒、冠状病毒在内的众多病毒中高度保守,甚至延伸到哺乳动物。在这里,我们观察到 SARS-CoV-2 的 2'-O-MTase 活性比 SARS-CoV 更强,尽管存在持续活跃的催化中心。我们进一步确定了关键残基(Leu-36、Asn-138 和 Ile-153),它们是 SARS-CoV-2 和 SARS-CoV 之间 2'-O-MTase 活性差异的决定因素。这些残基显著提高了 2'-O-MTase 的 RNA 结合亲和力,并增强了其对 RNA 底物的多功能性。有趣的是,nsp16 内的三个残基取代(Leu→Ile、Asn→His、Ile→Leu,从 SARS-CoV-2 到 SARS-CoV)导致病毒 2'-O 甲基化的比例降低,病毒复制受损。此外,它导致体外和体内的 I 型干扰素(IFN-I)和促炎细胞因子的显著上调,依赖于黑色素瘤分化相关蛋白 5(MDA5)和遗传学和生理学实验室 2(LGP2)的协同感应。总之,我们的研究结果表明,2'-O-MTase 中除 K-D-K-E 以外的残基的改变可能会影响病毒复制,进而影响发病机制。监测 nsp16 残基的变化至关重要,因为它可能有助于识别和评估由于 nsp16 中自然发生的突变导致的病毒致病性的未来变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/e85cab4c5f31/41392_2024_1860_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/75aded6cd6ab/41392_2024_1860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/ef3b88a8edf8/41392_2024_1860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/a354bc301d17/41392_2024_1860_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/c02413584895/41392_2024_1860_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/71160b3ba3a4/41392_2024_1860_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/e85cab4c5f31/41392_2024_1860_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/75aded6cd6ab/41392_2024_1860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/ef3b88a8edf8/41392_2024_1860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/a354bc301d17/41392_2024_1860_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/c02413584895/41392_2024_1860_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/71160b3ba3a4/41392_2024_1860_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/11137015/e85cab4c5f31/41392_2024_1860_Fig6_HTML.jpg

相似文献

1
Natural evidence of coronaviral 2'-O-methyltransferase activity affecting viral pathogenesis via improved substrate RNA binding.通过改善底物 RNA 结合提高冠状病毒 2'-O-甲基转移酶活性影响病毒发病机制的自然证据。
Signal Transduct Target Ther. 2024 May 29;9(1):140. doi: 10.1038/s41392-024-01860-x.
2
Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.严重急性呼吸综合征冠状病毒突变体缺乏 2'-O-甲基转移酶活性的衰减和恢复。
J Virol. 2014 Apr;88(8):4251-64. doi: 10.1128/JVI.03571-13. Epub 2014 Jan 29.
3
Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.冠状病毒nsp10/nsp16甲基转移酶可在体外和体内被源自nsp10的肽靶向,以减少复制和发病机制。
J Virol. 2015 Aug;89(16):8416-27. doi: 10.1128/JVI.00948-15. Epub 2015 Jun 3.
4
Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.对 SARS-CoV-2 2'-O-甲基转移酶的结构和功能的深入了解。
Virol Sin. 2024 Aug;39(4):619-631. doi: 10.1016/j.virs.2024.07.001. Epub 2024 Jul 3.
5
The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)BQ.1.1和XBB.1.16谱系中的NSP6-L260F替代可弥补由NSP13和NSP14突变导致的病毒聚合酶活性降低。
J Virol. 2025 Jun 17;99(6):e0065625. doi: 10.1128/jvi.00656-25. Epub 2025 May 13.
6
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
7
A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance.冠状病毒 nsp13-解旋酶的突变会损害其酶活性,并赋予瑞德西韦部分耐药性。
mBio. 2023 Aug 31;14(4):e0106023. doi: 10.1128/mbio.01060-23. Epub 2023 Jun 20.
8
Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.SARS 冠状病毒 RNA 核糖 2'-O-甲基化的机制的生化和结构见解:由 nsp16/nsp10 蛋白复合物介导。
PLoS Pathog. 2011 Oct;7(10):e1002294. doi: 10.1371/journal.ppat.1002294. Epub 2011 Oct 13.
9
A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2'-O methylation of its first nucleotide.一种金属离子使 SARS-CoV-2 mRNA 定向,以确保其第一个核苷酸的 2'-O 甲基化准确无误。
Nat Commun. 2021 Jun 2;12(1):3287. doi: 10.1038/s41467-021-23594-y.
10
Reposition pathways of GTP in NS5-methyltransferase revealed by enhanced molecular dynamics simulations.通过增强分子动力学模拟揭示NS5-甲基转移酶中GTP的重新定位途径
Phys Chem Chem Phys. 2025 Jun 18;27(24):12738-12751. doi: 10.1039/d5cp00438a.

引用本文的文献

1
Evolutionary Origins and Functional Diversification of 2'-O-Methyltransferases: Insights from Phylogenetic and Structural Analysis.2'-O-甲基转移酶的进化起源与功能多样化:系统发育和结构分析的见解
Int J Mol Sci. 2025 May 30;26(11):5260. doi: 10.3390/ijms26115260.
2
Leveraging plant-derived nanovesicles for advanced nucleic acid-based gene therapy.利用植物源纳米囊泡进行先进的基于核酸的基因治疗。
Theranostics. 2025 Jan 1;15(1):324-339. doi: 10.7150/thno.104507. eCollection 2025.
3
SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis.

本文引用的文献

1
An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivo.一种优化的高通量 SARS-CoV-2 双报告基因转互补系统,用于体外和体内抗病毒筛选。
Virol Sin. 2024 Jun;39(3):447-458. doi: 10.1016/j.virs.2024.03.009. Epub 2024 Mar 26.
2
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations.暴发信息基因组报告:可扩展和动态监测 SARS-CoV-2 变体和突变。
Nat Methods. 2023 Apr;20(4):512-522. doi: 10.1038/s41592-023-01769-3. Epub 2023 Feb 23.
3
Inhibition of cellular RNA methyltransferase abrogates influenza virus capping and replication.
N蛋白中SARS-CoV-2的特异性适应性变化抑制NF-κB激活并改变发病机制。
J Cell Biol. 2025 Jan 6;224(1). doi: 10.1083/jcb.202404131. Epub 2024 Dec 16.
4
Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.对 SARS-CoV-2 2'-O-甲基转移酶的结构和功能的深入了解。
Virol Sin. 2024 Aug;39(4):619-631. doi: 10.1016/j.virs.2024.07.001. Epub 2024 Jul 3.
抑制细胞RNA甲基转移酶可消除流感病毒的加帽和复制。
Science. 2023 Feb 10;379(6632):586-591. doi: 10.1126/science.add0875. Epub 2023 Feb 9.
4
NSUN2-mediated Mc methylation of IRF3 mRNA negatively regulates type I interferon responses during various viral infections.NSUN2 通过 Mc 甲基化修饰 IRF3 mRNA,从而在多种病毒感染过程中负调控 I 型干扰素应答。
Emerg Microbes Infect. 2023 Dec;12(1):2178238. doi: 10.1080/22221751.2023.2178238.
5
SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.SARS-CoV-2 利用非结构蛋白 16 逃避 IFIT1 和 IFIT3 的限制。
J Virol. 2023 Feb 28;97(2):e0153222. doi: 10.1128/jvi.01532-22. Epub 2023 Feb 1.
6
Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restriction.Nsp16 使 SARS-CoV-2 免受有效的 MDA5 感应和 IFIT1 介导的限制。
EMBO Rep. 2022 Dec 6;23(12):e55648. doi: 10.15252/embr.202255648. Epub 2022 Oct 26.
7
mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2.表达针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的同源原型/奥密克戎和异源嵌合受体结合域二聚体的信使核糖核酸(mRNA)疫苗。
Cell Res. 2022 Nov;32(11):1022-1025. doi: 10.1038/s41422-022-00720-z. Epub 2022 Sep 14.
8
N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.冠状病毒 RNA 帽的 N7-甲基化是通过阻止先天免疫识别而实现最大毒力所必需的。
mBio. 2022 Feb 22;13(1):e0366221. doi: 10.1128/mbio.03662-21. Epub 2022 Jan 25.
9
Coronaviral RNA-methyltransferases: function, structure and inhibition.冠状病毒 RNA 甲基转移酶:功能、结构和抑制。
Nucleic Acids Res. 2022 Jan 25;50(2):635-650. doi: 10.1093/nar/gkab1279.
10
Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase.SARS-CoV-2 Nsp10-Nsp16 甲基转移酶的底物特异性。
Viruses. 2021 Aug 30;13(9):1722. doi: 10.3390/v13091722.